The search for new Alzheimer's treatments just faced another setback — and now everything hinges on an approach that's already run into trouble
Moreover, the field may need a better understanding of Alzheimer's disease, she said, because basic science about how a disease works guides how drugs are developed. Beta-amyloid is probably still involved in Alzheimer's disease, but other factors could be too, including another protein called tau, factors affecting blood flow, and more.
Young also called other advanced experimental Alzheimer's disease drugs, including BAN2401 and elenbecestat, a different type of drug called a BACE inhibitor that is also from Biogen and Eisai,"more risky."Biogen, for its part, told Business Insider in a statement that"it is premature to draw any conclusion before we have fully analyzed the data," which is what it's now doing.
Ever try cannabis for that
The🔑key to solving Alzheimer’s is NOT thru medicine but thru the kind of DIET one must observe starting age 40yrs old or younger. The right food groups&combination of vitamins, exercise; lifestyle change for healthier mind, body, spirit healing, positive attitude& mindfulness.
I think its delusional to think that big pharma actually wants to cure anything. Anything at all whose existence is generates revenue.